Carbidopa And Levodopa
Product Images NDC 0378-0085

5 FDA label images from Mylan Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 0378-0085). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Image 01
Chemical structure of Carbidopa, one of the active ingredients in Carbidopa and Levodopa. The structure includes a phenol group with two hydroxyls, a hydrazine moiety, and a water molecule indicating a hydrate form.*
FDA Label Image

Image 02

Image 02
Chemical structure diagram depicting the active ingredient Levodopa, showing its molecular skeleton including hydroxyl groups, amine group, and carboxylic acid group, consistent with the Carbidopa and Levodopa product.*
FDA Label Image

Image 03

Image 03
Label for Carbidopa and Levodopa tablets, USP, containing 10 mg Carbidopa and 100 mg Levodopa per tablet, manufactured by Mylan Pharmaceuticals Inc. The label shows the NDC number 0378-0078-01 and indicates a 100-tablet package. It includes storage instructions, child-resistant container use, and a note that the product is Rx only. The label states the product is made in Australia and is varnish free for serialization.*
FDA Label Image

Image 04

Image 04
Label for Carbidopa and Levodopa tablets, USP, 25 mg/100 mg, manufactured by Mylan Pharmaceuticals Inc. The label includes the NDC 0378-0085-01, packaging details of 100 tablets per container, and dosage strengths. It features storage instructions, a barcode, and the Mylan logo with website information.*
FDA Label Image

Image 05

Image 05
Label for Carbidopa and Levodopa tablets, USP, showing strengths of 25 mg Carbidopa and 250 mg Levodopa per tablet. The label includes the NDC number 0378-1133-01, manufacturer Mylan Pharmaceuticals Inc., and packaging information for 100 tablets. Instructions note the tablets are varnish free for serialization and include storage and dispensing guidelines.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.